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التغيرات فى الوزن والبروتينات والمكونات النيتروجينية غير البروتينية وتركيب الكلي 
  بعقار الجاليبنكالميد بالسكرى المصاحبة لعالج الفئران المصابة
تـم دراسة تأثير إعطاء عقار جاليبنكالميد للجرذان المصابة بمرض السكري المعاملة بمركب  :ملخـص 
لبروتينات والمكونات النيتروجينية غير البروتينية وكذلك على التغيرات األلوكسـان علـى وزن الجسم وا 
أوضحت نتائج تلك الدراسة أن هناك نقصاً ملحوظاً في وزن كل من . النسـيجية فـي كلـى تلك الجرذان 
% 21.14 , 36.37الجـرذان المصابة بالسكري وتلك المعالجة بعقار جاليبنكالميد وقد وصل النقص إلى 
، كما لوحظ نقص ملموس فى البروتين واأللبيومين بمصل الفئران المصابة بالسكري وقد علـى الترتيـب 
مقارنة بالمجموعة الضابطة، أما عند المعالجة  على الترتيب % 21.74, 20.19النقص إلى وصلت نسبة 
لوحظ . على الترتيب  7.75% , 3.30النقص غير ملموسة وتمثل بعقـار جاليبنكالمـيد أصـبحت نسبة 
  24.17% النقص إلى ص ملموس فى الجلوبيولين بمصل الفئران المصابة بالسكري وقد وصلت نسبة نق
5.0مقارنـة بالمجموعة الضابطة، أما المجموعة التى عولجت بعقار جاليبنكالميد فقد سجلت زيادة بنسبة 
ل الفئران المصابة أوضحت النتائج  زيادة ملموسة في تركيز البولينا بمص .  مقارنة بالمجموعة الضابطة %
مقارنة بالمجموعة الضابطة ولم تستطع المعاملة  154.99% بالسـكري وقـد وصلت نسبة الزيادة إلى 
لوحظ نقص عام في تركيز حمض البوليك فى . بالجاليبنكالميد من إعادة نسبة البولينا إلى الوضع الطبيعي 
أيضا . سبوعين األخيرين من الدراسة مجموعـة الجرذان المصابة بالسكري والذى أصبح ملموسا خالل اإل 
النقص إلىتركـيز الكرياتينيـن سـجل نقـص ملمـوس فى الفئران المصابة بالسكري وقد وصلت نسبة 
إستطاع الجاليبنكالميد من إعادة نسبة حمض البوليك والكرياتينين . مقارنة بالمجموعة الضابطة  %37.04
ية لكلى الجرذان المصابة بالسكر أنها تعاني من أوضحت الدراسة النسيج . قريـبا مـن الوضـع الطبيعي 
تغـيرات مرضـية على هيئة تكدس في الشعيرات الدموية الكلوية حيث تضخمت الطبقة الطالئية المبطنة 
لهـذه الشـعيرات مـع احـتوائها على أنوية متحللة، هذا باإلضافة إلى حدوث انتفاخات سحابية في خاليا 
يدة واختفاء الحافة المشطية لألنيبيبة الملتفة القريبة، كما تنقبض شعيرات الكلية األنيبيبة الملتفة القريبة والبع 
وتكون مصحوبة بتحلل التهابي مزمن يظهر من خالل ظهور خاليا لمفية وخاليا دم حمراء ، هذا وقد أدى 
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 موجودة اعطـاء عقـار الجاليبنكالميد إلى حث الكلية على الشفاء إال أن بعض التغيرات السابقة ما زالت 
 .بصورة محدودة على هيئة انكماش وانتفاخات سحابية
 
ABSTRACT The effect of glibenclamide administration to alloxan diabetic rats on 
body weight, protein profile and non-protein nitrogen constituents has been 
assessed.  Histological changes of kidney were also studied. Diabetic and 
glibenclamide-treated animals showed significant decrease in body weight gain 
from controls recording percentage values of 36.37% and 21.14%, respectively 
throughout the study.  Highly significant decrease in serum total protein and 
albumin levels was recorded in diabetic rats throughout the study with percentage 
decrease of 21.74% and 20.19%, respectively as compared to control levels.  This 
decrease is rendered to be not significant on glibenclamide treatment showing 
percentage decrease of 3.30% and 7.75%, respectively.  The estimated levels of 
serum globulin in diabetic rats showed significant decrease with a percentage of 
24.17% compared to controls.  However, non-significant flactuations in globulin 
levels were achieved upon glibenclamide administration during the whole 
experimental period with percentage increase of 5.0% as compared to controls.  A 
highly significant increase in serum urea concentration of diabetic animals has been 
observed.  The highest increment reached was at the eighth week where urea 
recorded 97.33 mg/dl with a percentage increase of 154.99% as compared with 
control group.  Glibenclamide did not manage to retain urea to normal level. Uric 
acid concentration was generally decreased in diabetic group and this decrease 
reached a significant value during the last two weeks of the study.  Also, creatinine 
concentration was decreased significantly in diabetic animals recording a 
magnitude of 37.04% compared to control. However, glibenclamide administration 
managed to return uric acid and creatinine concentrations near to normal levels.  
Histopathological changes in kidney of diabetic rats were represented by condensed 
capillaries of glomeruli where the epithelia of these capillaries were hypertrophied 
and possessed pyknotic nuclei.  Necrotic changes in proximal and distal convoluted 
tubules, loss of inner brush border lining proximal convoluted tubules, 
degeneration and infiltration of glomerular tufts by chronic inflammatory cells and 
red blood cells, swelling of tubular epithelium and enlargement of mesangial cells 
were also observed.  On treatment with glibenclamide recovery was manifested in a 
general manner but limited parts of urineferous tubules designated earlier 
manifested diabetic changes of degeneration and cloudy swelling. 
Key words: Diabetic rats, glibenclamide, Kidney structure, protein profile, 
non-protein nitrogen constituents. 
 
INTRODUCTION 
Diabetes  mellitus  is a disorder  in  which  the  level  of blood glucose is  
persistently  raised  above  the  normal   range.  It  may  result  from   either 
lack  of  pancreatic   insulin   secretion   or  resistance  to  insulin action.  There 
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are many associated metabolic abnormalities with diabetes mellitus notably 
ketoacidosis, the progressive development of disease of capillaries of the 
kidney and retina, damage to the peripheral nerves and excessive 
arteriosclerosis (World Health Organization, WHO, 1980).  On sever insulin 
lack, hyperketonaemia will developed together with alterations of lipid and 
protein turnover (Watkins et al., 1990).  In addition, diabetes mellitus initiates 
loss of body weight (Rungby et al., 1992 and Hotta et al., 1996). 
The influence of diabetes on structure and function of the kidney 
together with protein profile is a matter of concern for many researchers.  Porte 
and Halter (1981) recorded that hypoalbuminemia is a common problem in 
diabetic animals and is generally attributed to the presence of diabetic 
nephropathy.  Hepatic levels of albumin and its mRNA were found to be 
decreased in diabetes mellitus (Jefferson et al., 1983; Peavy et al., 1985 and 
Wanke & Wong, 1991).  Mansour et al., (2002) demonstrated that total protein 
and albumin were significantly decreased in alloxan diabetic rats.  Elevated 
levels of urea were recorded in diabetes (Annamalia & Augusti, 1980 and 
Akimoto et al., 2000).  However, uric acid and creatinine concentrations were 
shown to be decreased (Ganong, 1995). 
Edress et al., (1979) studied the histological changes in the kidney of 
alloxan diabetic rats. The first changes were observed in the form of thickening 
of the glomerular basement membrane and deposition of hyaline substance 
around the walls of the glomerular blood capillaries and in the mesangeal 
areas.  Glomerular filtration rate is elevated and is correlated to the increased 
filtration surface (Hirose et al., 1980 and Christiansen, 1984).  Several 
histological features correlating with renal function have been described in 
diabetic nephropathy.  These include mesangial expansion, glomerular size, 
capillary filtration surface, obliteration of glomeruli and increased interstitial 
fibrosis (Steffes et al., 1989; Osterby et al., 1990 and Yanardag et al., 2002).  
In some studies, these features correlate with each other and with glomerular 
filtration rate and albuminuria (Lane et al., 1993). 
Glibenclamide therapy in diabetic subjects was an attractive strategy for 
many investigators (Ashcroft and Ashcroft, 1992a; Kecskemeti et al., 2002 
and Kulkarni et al., 2002).  Although  diabetes mellitus has become a widely 
spread disease in Gaza strip, only few reports addressed the problem.  The 
current study has been intended to through more light on the relationship 
between diabetes and the changes in protein profile and kidney structure and 
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function. Assessment of the therapeutic effect of glibenclamide all over the 
treatment period of eight weeks was also followed.  Glibenclamide, a second-
generation sulfonylurea, was the drug of choice as it is commonly used for the 
treatment of diabetes mellitus in Gaza Strip.     
MATERIALS AND METHODS 
Experimental Animals 
Male albino rats were the chosen experimental animals for the present study.  
They were young adults weighing 90-110 gm.  Animals were normal and 
healthy.  They were housed in well-aerated cages under normal environmental 
conditions of temperature and humidity.  Animals were fed on commercial 
balanced diet and tap water was offered ad libitum all over the experimental 
period. 
Induction of diabetes and treatment 
Animals were allocated into two major groups: A control group and an 
experimental group.  The control group was orally administrated with saline 
solution.  The experimental group was fasted for 24 hours and then rendered 
diabetic by a single intraperitoneal injection of a freshly prepared alloxan 
monohydrate solution at a dose of 150 mg/kg body weight (Halim et al., 1977).  
The chosen diabetic animals (Rats with blood glucose level >200 mg/dl) were 
subdivided into two sub-groups: The rats of the first sub-group remained 
without treatment and considered as diabetics.  Animals of the second sub-
group were orally administrated with glibenclamide at a dose of 36 mg/kg body 
weight, daily all over the experimental duration of eight weeks and considered 
as treated diabetics.  Glibenclamide (commercially known as glucocare) was 
purchased from local pharmacies as tablets and then grinded using a mortar.  
The powder was dissolved in water and administrated to animals using a 
stomach tube with a smooth tip to protect the interior lining of the oral and 
buccal cavity from injury. 
Morphological studies 
Animals were individually weighed at weekly intervals in order to detect any 
changes in their body weights.  A sensitive balance was used and weights were 
recorded to the nearest gram.  Dead animals were recorded daily in order to 
calculate the percentage of mortality each week . 
Physiological Studies 
Animals from both control and experimental groups were decapitated weekly.  
Blood samples were collected in 10 ml plain tubes for serum preparation.  
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Clear serum samples were separated by centrifugation at 3000 r.p.m. for 20 
min. Serum total protein was determined according to the biuret reaction as 
designated by Armstrong and Carr (1964).  The kits were purchased from 
Biotech laboratories U.K.  Serum albumin was determined using RANDOX 
reagent kits and following their instruction manual according to the method of 
Doumas et al., 1971.  The concentrations of globulin were calculated by the 
following equation: Concentration of globulins (gm/dl) = Total protein – 
Albumin.  Urea determination is based upon the cleavage of urea with urease 
(Berthelot’s reaction) according to Fawcett and Scott (1960).  The kit was 
purchased from Boehringer Mannaheim GmbH Diagnostica.  Serum uric acid 
was determined using the SPINREACT reagent kits and following their 
instruction manual described by Fossatti et al., 1980.  Serum creatinine was 
determined without protein precipitation according to Bartels et al., 1972 using 
the DiaSys reagent kits. 
Histological Studies 
Following decapitation, the kidney was dissected from the surrounding 
connective tissues and organs.  It was then excised and immediately immersed 
in saline solution for the removal of blood.  The preparation was then fixed in 
10% buffered formaline (Lillie, 1954).  Fixed tissue was dehydrated, cleared 
with xylene and completely impregnated with paraffin wax.  The tissue was 
then sectioned by a rotary microtome at a thickness of 3µm, mounted and 
affixed to slides and later used for the routine haematoxylin and eosin stain 
(Harris, 1900). 
Statistical Analysis 




Table 1 demonstrates the average weekly body weight of both control and 
experimental groups.  It is obvious that control animals showed progressive 
increase in body weights with the lapse of time.  The rate of increase in body 
weight amounted to 134.89% at the end of the experiment when calculated in 
terms of their original weights.  Gradual increase in the body weight of diabetic 
rats took place till the end of the study where it reached a maximum value of 
only 47.20% of their original weight with a difference of 87.69% from 
controls.  Also, rats treated with glibenclamide showed gradual increase in 
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body weights till the end of the eight week.  The increase amounted to 80.45% 
of their initial weights with a difference of 54.44% from control animals.  No 
mortalities were recorded in both control and glibenclamide treated rats.  
However, in the sixth week of the experiment, the mortality rate increased in 
the diabetic rats and recorded 16.66%.  Moreover, extra mortalities were 
recorded in the eighth week, with  percentage of 20.0%. 
Physiological studies 
The mean values of serum total protein, albumin and globulin of both control 
and experimental animals are presented in table 1.  Serum total protein level 
showed a highly significant decrease in diabetic rats throughout the study with 
a percentage value of 21.74% compared to controls.  However, there was a non 
significant decrease in serum total protein of treated diabetic animals recording 
a percentage decrease of only 3.30% as compared to controls.  Also, a highly 
significant decrease in serum albumin levels of diabetic rats was recorded 
compared to that of controls recording a percentage decrease of 20.19%.  This 
decrease rendered to be not significant in animals treated with glibenclamide 
with a percentage decrease of 7.75% as compared to the control group.  Serum 
globulin levels in diabetic rats exhibited significant decrease with a percentage 
of 24.17% compared to controls.  However, globulin levels in treated diabetic 
animals showed non-significant fluctuations during the whole experimental 
period with percentage increase of 5.0% as compared to control group. Table 2 
illustrates the average serum urea, uric acid and creatinine concentrations of 
both control and experimental groups.  A highly significant increase in urea 
concentration of diabetic animals has been observed.  The highest increment 
reached was at the eighth week where it recorded 97.33 mg/dl with a 
percentage increase of 154.99% as compared with control group.  
Nevertheless, the mean value of the treated diabetic animals for urea was also 
significantly increased throughout the study recording a percentage increase of 
59.47% as compared to control group.  Uric acid concentrations were generally 
decreased among diabetic animals and this decrease become significant and 
reached its maximum value of 23.70% during the last two weeks of the study.  
On glibenclamide treatment such decrease is rendered to be non-significant 
showing a percentage of 5.78% as compared to control. Serum creatinine levels 
of diabetic rats showed highly significant decrease commencing from the 
second week of the study with a percentage of 37.04% as compared to control 
group.   
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The mean value of serum creatinine concentrations for the treated diabetic 
group showed non-significant decrease with a percentage of 5.56% as 
compared to control group. 
Histological studies 
Fig. 1 presented kidney section of control albino rat showing normal 
glomerulus surrounded by Bowman’s capsule, proximal and distal convoluted 
tubules.  Histological examination of kidney from diabetic rats is shown in Fig. 
2.  Histopathological changes were represented by condensed glomeruler 
capillaries where the epithelia of these capillaries were hypertrophoid and 
possess pyknotic nuclei. In addition, necrotic changes in proximal and distal 
convoluted tubules; cloudy swelling in the lining cells of proximal and distal 
convoluted tubules with pyknotic nuclei, loss of inner brush border of proximal 
convoluted tubules; completely ereded proximal convoluted tubules were also 
manifested. The glomerular tufts were obviously contracted, lobulated 
degenerated and infeltrated by chronic inflammatory cells and RBCs. The 
glomeruli were more or less shrunken. The urinary spaces became wide and the 
interstitial connective tissue was invaded by chronic inflammatory cells mainly 
lymphocytes. Finally. The nuclei of some deteriorated cells displayed obvious 
signs of karyorrhexis while a few of these nuclei were markedly karyolysed.  
Treatment with glibenclamide rendered the kidney susceptible to recovery but 
at quite slow rate (Fig. 3).  The prementioned lesions from diabetes induction 
were still designated in the earlier weeks of glibenclamide administration in the 
form of vacuolation within glomerular tuft; infiltration of glomeruli with 
inflamatory cells; degenerative changes and cloudy swelling within convoluted 
tubules; appearence of pyknotic nuclei in urineferous tubules and deposited 
extracellular hyaline material in between tubules. Although, glibenclamide 
managed to stimulate early regenerative features commecncing from the fifth 
week of treatment yet some histological lesions still persisted as shrunken 
deeply stained glomeruli; altered urineferous tubules and obliteration, of some 
lumens. At the end of the investigation, recovery was manifested in a general 
manner except limited parts of urineferous tubules designated earlier 
manifested diabetic changes of degeneration and cloudy swelling. On the other 
hand, the glomeruli seemed to undergo recovery. Distribution of cells, visceral 
epithelial cells and mesangial cells within the glomeruli attained near to normal 
features.   
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It could be deduced that diabetes causes pathological alterations in many 
physiological and histological aspects and glibenclamide was managed to 
alleviate most of them. 
DISCUSSION 
Morphological Studies 
The observed decrease in body weight following experimental diabetes  
mellitus is in agreement with previous studies (Rungby et al., 1992; Hotta et 
al., 1996 and Badr-Eldin et al., 1998).  This may be attributed to different side 
effects of inability to use carbohydrates including lypolysis, glycogenolysis and 
acidosis. It also may be attributed to disturbances in one or many metabolic 
pathways and due to deficiency of protein or disturbances in different 
enzymatic activities. However, diabetic rats treated with glibenclamide showed 
increase in body weight which may be explained by increased insulin secretion 
or increased food consumption (Fernstrom & Fernstrom, 1993 and Farouque & 
Meredith, 2003).  
Physiological investigation 
The decrease in serum total protein observed in diabetic rats is coincide with 
the findings of Peavy et al., (1985) and Wanke & Wong (1991).  This decline 
may be due to the inhibited oxidative phosphorylation processes which lead to 
decrease of protein synthesis, increase in the catabolic processes and reduction 
of protein absorption.  Two mechanisms may account for the alterations in 
protein synthesis in diabetic rats. First, the defect in hepatic protein synthesis 
resulting from insulin deficiency was most likely due to a decrease in the 
amount of mRNA bound to ribosomes, leading to a decrease in the hepatic 
polysome population (Tragl & Reaven, 1972 and Jefferson et al., 1983).  
Second is the reduction in the number of ribosomal protein synthesis (Wool et 
al., 1966), thus the capacity of the tissue for protein synthesis is decreased.  
Transport and uptake of amino acids in peripheral tissues are depressed, 
causing an elevated circulating level of amino acids particularly alanine which 
further enhance gluconeogenesis in the liver. Decline in ATP production and 
direct requirement for insulin- protein synthesis is decreased in all tissues 
(Ganong, 1995).  The efficiency of glibenclamide to restore total protein 
concentrations is presumably due to its ability to increase insulin secretion 
(Annamalia & Augusti, 1980; Fernstrom & Fernstrom, 1993 and Farouque & 
Meredith, 2003). The proposed sites of action include hepatic uptake of 
glucogenic amino acids, stimulation of amino acid incorporation into protein  




Fig. 1. Histological examination of kidney tissue of normal albino rats, showing; (A) the glomerulus (g ), 
surrounded by Bowman’s capsule   (  ); outer and inner visceral layers and a capsular space ( * ). The 
proximal (P) and distal (d ) convoluted tubules. [HX - E; X132]; (B) glomerular epithelium; mesangial cells 




Fig. 2. Photomicrograph of kidney tissues of diabetic rats showing (A) necrotic lesions of  both proximal 
and distal convoluted tubules.[HX - E; X132]; (B) contraction lobulation and degeneration of the 
glomerular tufts; wide urinary (capsular) space ( * ) [HX - E; X132]; (C) shrunken and lobulated glomeruli 
infiltrated by chronic inflammatory cells and RBCs. [HX-E; X132]; (D) karyorrhexis of some deterioratic 












Fig. 3.  Light micrograph of kidney tissue of rats treated with glibenclamide showing (A) vacuolations 
together with inflammatory cells and RBCs within the glomerular tuft [HX - E; X132]; (B) chronic 
inflammatory cells ( ) invading the interstitial connective tissue. [HX - E; X66]; (C) remnants of 
necrotic cells   (+) occupying the capsular space [HX – E; X 132];  (D) near to normal feature. Notice; the 
distribution of cells, visceral epithelial cells and masengeal cells within the glomeruli. (r) in other cells. 
[HX – E; X 132]. 
 
and decreased proteolysis by activation and synthesis of transaminases and 
other enzymes catalyzing amino acids transamination. The decrease in albumin 
level documented for diabetic rats may be due to liver massive necrosis, 
deterioration of liver function, hepatic resistance to insulin and glycogen 
impairment of oxidative phosphorylation (Ezzat et al., 1989; Guler et al., 1994 
and Rao, 1995).  Nevertheless, hypoalbuminemia is a common problem in 
diabetic animals and is generally attributed to the presence of diabetic 
nephropathy (Porte & Halter, 1981).  Under the same experimental conditions 
serum globulin level revealed an appreciable decrease. Such results were 
substantiated by Tragl & Reaven (1972) and Wanke & Wong (1991). 
Previous studies have shown that hepatic levels of albumin and its mRNA are 
decreased within 3 days following the onset of diabetes mellitus (Jefferson  et 
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globulin, administration of glibenclamide to diabetic rats did not successfully 
restore albumin concentration to the normal level, suggesting the necessity for 
a longer duration of treatment. The highly significant increase in serum urea 
concentrations of diabetic rats may be due to depletion of serum protein, 
increase in the rate of circulating amino acids and deamination takes place that 
consequently leads to the formation of large amount of ammonia which is 
eventualy converted to urea. The breakdown of amino acids during 
gluconeogenesis in the liver results in increased production of urea, fostering 
negative nitrogen balance (Ganong, 1995). Glibenclamide potentiated a 
substantial decrease in urea concentration, but this still far away from normal 
control levels. This result is in conformity with Annamalia & Augusti (1980) 
and Fernstrom & Fernstrom (1993) and may be primarily due to nephropathy.  
A general decrease in uric acid concentration in the diabetic rats was only 
vendicated during the latter weeks. Uric acid represents the ultimate catabolic 
of purines. Uric acid can be absorbed across the renal mucosa and excreted in 
urine as uric acid per se (Guggino et al., 1983). Nevertheless, glibenclamide 
intake enhanced the previous concentrations to meet with near to normal levels.  
Alloxan diabetic rats initiated significant decline in creatinine concentration 
that commenced from the second week onwards. Creatinuria occurs in any 
condition associated with extensive muscle breakdown as in starvation and 
poorly controlled diabetes mellitus (Ganong, 1995). This decline was amended 
to near to normal levels following treatment with glibenclamide. 
Histological studies 
The observed histopathologic changes in the kidney of alloxan diabetic rats 
including condensed capillaries of glomeruli, necrotic changes, loss of inner 
brush border lining proximal convoluted tubules, degeneration glomerular tufts 
and infiltration by chronic inflammatory cells and red blood cells and 
enlargement of mesangial cells are in agreement with the findings of Edress et 
al., (1979); Mauer et al., (1983); Steffes et al., (1989); Spadella et al., (1996) 
and Yanardag et al., (2002).  These changes may be due to an increase in the 
capillary permeability resulting in escape of plasma protein into the 
intercapillary spaces, and also in the mesangeal areas.  The presences of these 
abnormal exudates in the mesangium usually stimulate the process of 
proliferation of the mesangeal cells leading to appearance of new cells. It 
appears that the mesangium expanding into an inherently large or perhaps 
secondarily enlarged glomerulus will less affect peripheral capillary surface 
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than the same mesangium volume in a smaller glomerulus (Ellis et al., 1986 
and Osterby et al., 1988). Thus, the change in one component of the 
glomerulus must affect the volume available to other structures, e.g. glomerular 
capillaries. Mechanistically the mesangium impinges on the peripheral 
capillary surface and with sufficient pathological expansion, the enlarging 
mesangium will eventually comprise filtration surface and reduce glomerular 
filtration rate. Infiltration process begins shortly after an area of tissue has been 
damaged when capillaries and postcapillary venules in adjucent healthy tissue 
become dilated and blood flow within them slow. In general, it may be 
postulated that structural lesions of the glomerulus are the primary cause of 
loss of glomerular function in diabetic animals. Glibenclamide rendered the 
kidney susceptible to recovery but at quite slow rate.  Recovery is in the form 
of appearance of regenerative cells in variable areas of the urineferous tubules.  
It is worth mentioning that the concurrent histological finding come as a 
supportive factor for the initially obtained biochemical studies. The maintained 
high urea levels might be a normal sequel to nephropathy. Nevertheless, 
Spadella et al., (1996) came to the conclusion that treatment through pancreas 
transplantation in alloxan- induced diabetic rats prevent the development of 
kidney lesions only after 6 months post transplantation. This statement 
substantiates the present results of the requirement of a much longer period of 
treatment for stimulation of obvious recovery. 
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